You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Biodegradable Rectal Spacers for Prostate Cancer Radiotherapy

Version: n/a ID: RR 21-5 Jan 2019
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
P Chung, J Brown, D D’Souza, W Koll, S Morgan, and the biodegradable spacer insertion during radiotherapy for prostate cancer recommendation report group (SPACER RRG).

Guideline Objective

The objective of this guideline is to provide clinical practice recommendations for the use of biodegradable spacers for prostate cancer treatment.

Patient Population

Patients undergoing radiation treatment for localized prostate cancer

Intended Guideline Users

Radiation oncologists and genitourinary oncologists involved in the management of prostate cancer.

Research Questions

Does the use of biodegradable hydrogel spacers during RT for prostate cancer decrease rectal (and other) toxicities and maintain QOL following treatment?

pdf download Full Report (PDF) (474.07 KB)